These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12871326)

  • 21. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp).
    Brennan SO; Hammonds B; George PM
    J Clin Invest; 1995 Dec; 96(6):2854-8. PubMed ID: 8675656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fibrinogen Aalpha R16C mutation results in fibrinolytic resistance.
    Flood VH; Al-Mondhiry HA; Farrell DH
    Br J Haematol; 2006 Jul; 134(2):220-6. PubMed ID: 16846481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
    Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypofibrinogenaemia associated with a novel heterozygous gamma289 Ala -->Val substitution (fibrinogen Dorfen).
    Dear A; Brennan SO; Dempfle CE; Kirschstein W; George PM
    Thromb Haemost; 2004 Dec; 92(6):1291-5. PubMed ID: 15583736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinogen Hillsborough: a novel gammaGly309Asp dysfibrinogen with impaired clotting.
    Mullin JL; Brennan SO; Ganly PS; George PM
    Blood; 2002 May; 99(10):3597-601. PubMed ID: 11986213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel mutation (deletion of Aalpha-Asn 80) in an abnormal fibrinogen: fibrinogen Caracas VI. Consequences of disruption of the coiled coil for the polymerization of fibrin: peculiar clot structure and diminished stiffness of the clot.
    Marchi RC; Meyer MH; de Bosch NB; Arocha-Piñango CL; Weisel JW
    Blood Coagul Fibrinolysis; 2004 Oct; 15(7):559-67. PubMed ID: 15389122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
    Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).
    Meyer M; Kutscher G; Stürzebecher J; Riesener G; Lutze G
    Thromb Res; 2003 Jan; 109(2-3):145-51. PubMed ID: 12706644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
    Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J
    Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen γ-module.
    Asselta R; Robusto M; Braidotti P; Peyvandi F; Nastasio S; D'Antiga L; Perisic VN; Maggiore G; Caccia S; Duga S
    J Thromb Haemost; 2015 Aug; 13(8):1459-67. PubMed ID: 26039544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe bleeding in a woman heterozygous for the fibrinogen gammaR275C mutation.
    Rein CM; Anderson BL; Ballard MM; Domes CM; Johnston JM; Madsen RJ; Wolper KK; Terker AS; Strother JM; Deloughery TG; Farrell DH
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):494-7. PubMed ID: 20386430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypofibrinogenemia caused by a nonsense mutation in the fibrinogen Bbeta chain gene.
    Mimuro J; Hamano A; Tanaka T; Madoiwa KS; Sugo T; Matsuda M; Sakata Y
    J Thromb Haemost; 2003 Nov; 1(11):2356-9. PubMed ID: 14629469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gamma371 Thr-->Ile substitution in the fibrinogen gammaD domain causes hypofibrinogenaemia.
    Brennan SO; Wyatt JM; Fellowes AP; Dlott JS; Triplett DA; George PM
    Biochim Biophys Acta; 2001 Dec; 1550(2):183-8. PubMed ID: 11755207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low expression of truncated Aalpha chain variant in circulating fibrinogen.
    Brennan SO; Homer VM; Ockelford P; George PM
    Thromb Haemost; 2002 Sep; 88(3):533-4. PubMed ID: 12353086
    [No Abstract]   [Full Text] [Related]  

  • 35. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
    Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N
    Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Confirmation of mendelian properties of heterodimeric fibrinogen molecules in a heterozygotic dysfibrinogenemia, "fibrinogen Amarillo," using gprphoresis to differentiate semifibrin molecules from fibrinogen and fibrin.
    Shainoff JR; Ratnoff OD; Smejkal GB; DiBello PM; Welches WR; Lill H; Mitkevich OV; Periman P
    Thromb Res; 2001 Jan; 101(2):91-9. PubMed ID: 11342210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genotype and function analyses of four inherited dysfibrinogenemia pedigree caused by Arg16 amino acid substitution in fibrinogen Aα chain].
    Jiang LL; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):475-9. PubMed ID: 22967385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exon skipping and aberrant signal peptide cleavage produce novel fibrinogen with an Aα chain lacking the first 42 residues.
    Brennan SO; Laurie AD; McRae S
    Thromb Haemost; 2016 Aug; 116(3):581-5. PubMed ID: 27277572
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia.
    Asselta R; Spena S; Duga S; Peyvandi F; Malcovati M; Mannucci PM; Tenchini ML
    Haematologica; 2002 Aug; 87(8):855-9. PubMed ID: 12161363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization.
    Koopman J; Haverkate F; Briët E; Lord ST
    J Biol Chem; 1991 Jul; 266(20):13456-61. PubMed ID: 2071611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.